Actively Recruiting
Preventing Urinary Retention After Thoracic Surgery in Men 50 and Older Using Tamsulosin A Study to Reduce Post-Operative Urinary Problems Following Minimally Invasive Chest Surgery
Led by Hackensack Meridian Health · Updated on 2026-06-11
127
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research focuses on preventing post-operative urinary retention POUR, a common issue in men over 60 who have chest surgery. POUR causes discomfort and can lead to longer hospital stays and additional procedures like bladder catheter placement, which may cause infections and injury. The study aims to assess if giving the medication Flomax Tamsulosin daily starting one week before surgery can reduce this problem by relaxing the prostate. Participants receive one of two treatment schedules Tamsulosin 0.4 mg daily for either one week or three days before surgery, continuing after surgery until normal urination returns. This medication is FDA-approved for improving urinary flow in men with enlarged prostates and is commonly used for bladder issues related to urinary retention requiring catheterization. During the study, participants are monitored for urine volume within 8 hours after surgery to evaluate the medications effect. Researchers will track urinary function, symptoms, and any complications related to catheter use. The study is non-randomized and open-label, with follow-up continuing until normal voiding resumes, aiming to improve patient comfort and reduce catheter-related risks.
CONDITIONS
Brief Title
Post-operative Urinary Retention (POUR) Following Thoracic Surgery
Research Team
M
Michael Spallone, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here